APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Trial Design Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI Clinical Trial Design Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

12 August 2026195 pages

Choose your research edition.

Industry ResearchAI Clinical Trial Design Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Trial Design Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI Clinical Trial Design Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Trial Design Software Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Trial Design Software Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global AI Clinical Trial Design Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI Clinical Trial Design Software include Cytel, TriNetX, Saama, Simulations Plus, Statsols, ConcertAI, Phesi, Faro Health and QuantHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI Clinical Trial Design Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Clinical Trial Design Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Clinical Trial Design Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Clinical Trial Design Software market size, projected growth trends, production technologies, key applications, and end-use industries.

AI Clinical Trial Design Software Segment by Company

Cytel

TriNetX

Saama

Simulations Plus

Statsols

ConcertAI

Phesi

Faro Health

QuantHealth

Unlearn

MMS

Berry Consultants

ZS

Clinion

Nurocor

Lindus Health

TrialKey

Protocol Builder

Medidata

IQVIA

Certara

AI Clinical Trial Design Software Segment by Type

End-to-End Trial Design Platforms

Protocol Authoring and Optimization Software

Trial Simulation and Outcome Prediction Software

Adaptive and Bayesian Design Software

Feasibility and Enrollment Design Software

Synthetic Control and Digital Twin Software

AI Clinical Trial Design Software Segment by Application

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Medical Device and Diagnostics Companies

Academic and Medical Research Institutions

Government and Nonprofit Research Organizations

Other Clinical Research Organizations

AI Clinical Trial Design Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Design Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Design Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Design Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Clinical Trial Design Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Clinical Trial Design Software industry.

Chapter 3: Detailed analysis of AI Clinical Trial Design Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Clinical Trial Design Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Clinical Trial Design Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of End-to-End Trial Design Platforms Table 3. Key Players of Protocol Authoring and Optimization Software Table 4. Key Players of Trial Simulation and Outcome Prediction Software Table 3. Key Players of Adaptive and Bayesian Design Software Table 4. Key Players of Feasibility and Enrollment Design Software Table 5. Key Players of Synthetic Control and Digital Twin Software Table 6. Global AI Clinical Trial Design Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Pharmaceutical and Biotechnology Companies Table 8. Key Players of Contract Research Organizations Table 9. Key Players of Medical Device and Diagnostics Companies Table 10. Key Players of Academic and Medical Research Institutions Table 11. Key Players of Government and Nonprofit Research Organizations Table 12. Key Players of Other Clinical Research Organizations Table 13. Global AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Clinical Trial Design Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Clinical Trial Design Software Market Share by Region (2021-2026) Table 16. Global AI Clinical Trial Design Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Clinical Trial Design Software Market Share by Region (2027-2032) Table 18. AI Clinical Trial Design Software Industry Trends Table 19. AI Clinical Trial Design Software Industry Drivers Table 20. AI Clinical Trial Design Software Industry Opportunities and Challenges Table 21. AI Clinical Trial Design Software Industry Restraints Table 22. Global AI Clinical Trial Design Software Revenue by Company (US$ Million) & (2021-2026) Table 23. Global AI Clinical Trial Design Software Revenue Market Share by Company (2021-2026) Table 24. Global AI Clinical Trial Design Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global AI Clinical Trial Design Software Key Company Head Office and Area Served Table 26. Global AI Clinical Trial Design Software Company, Product Type & Application Table 27. Global AI Clinical Trial Design Software Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global AI Clinical Trial Design Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global AI Clinical Trial Design Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 32. Global AI Clinical Trial Design Software Market Size by Type (2027-2032) & (US$ Million) Table 33. Global AI Clinical Trial Design Software Revenue Market Share by Type (2021-2026) Table 34. Global AI Clinical Trial Design Software Revenue Market Share by Type (2027-2032) Table 35. Global AI Clinical Trial Design Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 37. Global AI Clinical Trial Design Software Market Size by Application (2027-2032) & (US$ Million) Table 38. Global AI Clinical Trial Design Software Revenue Market Share by Application (2021-2026) Table 39. Global AI Clinical Trial Design Software Revenue Market Share by Application (2027-2032) Table 40. Cytel Company Information Table 41. Cytel Business Overview Table 42. Cytel AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Cytel AI Clinical Trial Design Software Product Portfolio Table 44. Cytel Recent Development Table 45. TriNetX Company Information Table 46. TriNetX Business Overview Table 47. TriNetX AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. TriNetX AI Clinical Trial Design Software Product Portfolio Table 49. TriNetX Recent Development Table 50. Saama Company Information Table 51. Saama Business Overview Table 52. Saama AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Saama AI Clinical Trial Design Software Product Portfolio Table 54. Saama Recent Development Table 55. Simulations Plus Company Information Table 56. Simulations Plus Business Overview Table 57. Simulations Plus AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Simulations Plus AI Clinical Trial Design Software Product Portfolio Table 59. Simulations Plus Recent Development Table 60. Statsols Company Information Table 61. Statsols Business Overview Table 62. Statsols AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Statsols AI Clinical Trial Design Software Product Portfolio Table 64. Statsols Recent Development Table 65. ConcertAI Company Information Table 66. ConcertAI Business Overview Table 67. ConcertAI AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. ConcertAI AI Clinical Trial Design Software Product Portfolio Table 69. ConcertAI Recent Development Table 70. Phesi Company Information Table 71. Phesi Business Overview Table 72. Phesi AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Phesi AI Clinical Trial Design Software Product Portfolio Table 74. Phesi Recent Development Table 75. Faro Health Company Information Table 76. Faro Health Business Overview Table 77. Faro Health AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Faro Health AI Clinical Trial Design Software Product Portfolio Table 79. Faro Health Recent Development Table 80. QuantHealth Company Information Table 81. QuantHealth Business Overview Table 82. QuantHealth AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. QuantHealth AI Clinical Trial Design Software Product Portfolio Table 84. QuantHealth Recent Development Table 85. Unlearn Company Information Table 86. Unlearn Business Overview Table 87. Unlearn AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Unlearn AI Clinical Trial Design Software Product Portfolio Table 89. Unlearn Recent Development Table 90. MMS Company Information Table 91. MMS Business Overview Table 92. MMS AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. MMS AI Clinical Trial Design Software Product Portfolio Table 94. MMS Recent Development Table 95. Berry Consultants Company Information Table 96. Berry Consultants Business Overview Table 97. Berry Consultants AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Berry Consultants AI Clinical Trial Design Software Product Portfolio Table 99. Berry Consultants Recent Development Table 100. ZS Company Information Table 101. ZS Business Overview Table 102. ZS AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. ZS AI Clinical Trial Design Software Product Portfolio Table 104. ZS Recent Development Table 105. Clinion Company Information Table 106. Clinion Business Overview Table 107. Clinion AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Clinion AI Clinical Trial Design Software Product Portfolio Table 109. Clinion Recent Development Table 110. Nurocor Company Information Table 111. Nurocor Business Overview Table 112. Nurocor AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Nurocor AI Clinical Trial Design Software Product Portfolio Table 114. Nurocor Recent Development Table 115. Lindus Health Company Information Table 116. Lindus Health Business Overview Table 117. Lindus Health AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Lindus Health AI Clinical Trial Design Software Product Portfolio Table 119. Lindus Health Recent Development Table 120. TrialKey Company Information Table 121. TrialKey Business Overview Table 122. TrialKey AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. TrialKey AI Clinical Trial Design Software Product Portfolio Table 124. TrialKey Recent Development Table 125. Protocol Builder Company Information Table 126. Protocol Builder Business Overview Table 127. Protocol Builder AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Protocol Builder AI Clinical Trial Design Software Product Portfolio Table 129. Protocol Builder Recent Development Table 130. Medidata Company Information Table 131. Medidata Business Overview Table 132. Medidata AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Medidata AI Clinical Trial Design Software Product Portfolio Table 134. Medidata Recent Development Table 135. IQVIA Company Information Table 136. IQVIA Business Overview Table 137. IQVIA AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. IQVIA AI Clinical Trial Design Software Product Portfolio Table 139. IQVIA Recent Development Table 140. Certara Company Information Table 141. Certara Business Overview Table 142. Certara AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. Certara AI Clinical Trial Design Software Product Portfolio Table 144. Certara Recent Development Table 145. North America AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 146. North America AI Clinical Trial Design Software Market Size by Type (2027-2032) & (US$ Million) Table 147. North America AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 148. North America AI Clinical Trial Design Software Market Size by Application (2027-2032) & (US$ Million) Table 149. North America AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America AI Clinical Trial Design Software Market Size by Country (2021-2026) Table 151. North America AI Clinical Trial Design Software Market Size by Country (2027-2032) Table 152. Europe AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 153. Europe AI Clinical Trial Design Software Market Size by Type (2027-2032) & (US$ Million) Table 154. Europe AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 155. Europe AI Clinical Trial Design Software Market Size by Application (2027-2032) & (US$ Million) Table 156. Europe AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Europe AI Clinical Trial Design Software Market Size by Country (2021-2026) Table 158. Europe AI Clinical Trial Design Software Market Size by Country (2027-2032) Table 159. China AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 160. China AI Clinical Trial Design Software Market Size by Type (2027-2032) & (US$ Million) Table 161. China AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 162. China AI Clinical Trial Design Software Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 164. Asia AI Clinical Trial Design Software Market Size by Type (2027-2032) & (US$ Million) Table 165. Asia AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 166. Asia AI Clinical Trial Design Software Market Size by Application (2027-2032) & (US$ Million) Table 167. Asia AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Asia AI Clinical Trial Design Software Market Size by Country (2021-2026) Table 169. Asia AI Clinical Trial Design Software Market Size by Country (2027-2032) Table 170. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 171. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Type (2027-2032) & (US$ Million) Table 172. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 173. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Application (2027-2032) & (US$ Million) Table 174. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2021-2026) Table 176. South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2027-2032) Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. AI Clinical Trial Design Software Product Image Figure 2. Global AI Clinical Trial Design Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI Clinical Trial Design Software Market Share by Type: 2025 VS 2032 Figure 4. End-to-End Trial Design Platforms Image Figure 5. Protocol Authoring and Optimization Software Image Figure 6. Trial Simulation and Outcome Prediction Software Image Figure 7. Adaptive and Bayesian Design Software Image Figure 8. Feasibility and Enrollment Design Software Image Figure 9. Synthetic Control and Digital Twin Software Image Figure 10. Global AI Clinical Trial Design Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global AI Clinical Trial Design Software Market Share by Application: 2025 VS 2032 Figure 12. Pharmaceutical and Biotechnology Companies Image Figure 13. Contract Research Organizations Image Figure 14. Medical Device and Diagnostics Companies Image Figure 15. Academic and Medical Research Institutions Image Figure 16. Government and Nonprofit Research Organizations Image Figure 17. Other Clinical Research Organizations Image Figure 18. Global AI Clinical Trial Design Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 20. Global AI Clinical Trial Design Software Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global AI Clinical Trial Design Software Market Share by Players in 2025 Figure 23. Global Top 5 and 10 AI Clinical Trial Design Software Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global AI Clinical Trial Design Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global AI Clinical Trial Design Software Revenue Market Share by Type (2021-2032) Figure 27. Global AI Clinical Trial Design Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global AI Clinical Trial Design Software Revenue Market Share by Application (2021-2032) Figure 29. North America AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 30. North America AI Clinical Trial Design Software Market Share by Type (2021-2032) Figure 31. North America AI Clinical Trial Design Software Market Share by Application (2021-2032) Figure 32. North America AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 33. United States AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 34. Canada AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 35. Mexico AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 36. Europe AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 37. Europe AI Clinical Trial Design Software Market Share by Type (2021-2032) Figure 38. Europe AI Clinical Trial Design Software Market Share by Application (2021-2032) Figure 39. Europe AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 40. Germany AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 41. France AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 42. U.K. AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 43. Italy AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 44. Russia AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 46. China AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 47. China AI Clinical Trial Design Software Market Share by Type (2021-2032) Figure 48. China AI Clinical Trial Design Software Market Share by Application (2021-2032) Figure 49. Asia AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 50. Asia AI Clinical Trial Design Software Market Share by Type (2021-2032) Figure 51. Asia AI Clinical Trial Design Software Market Share by Application (2021-2032) Figure 52. Asia AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 53. Japan AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 54. South Korea AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 57. India AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 58. Australia AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa AI Clinical Trial Design Software Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa AI Clinical Trial Design Software Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 63. Brazil AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 64. South Africa AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 66. Turkey AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 67. Argentina AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 68. UAE AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 69. Egypt AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 70. Chile AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • End-to-End Trial Design Platforms
  • Protocol Authoring and Optimization Software
  • Trial Simulation and Outcome Prediction Software
  • Adaptive and Bayesian Design Software
  • Feasibility and Enrollment Design Software
  • Synthetic Control and Digital Twin Software
Applications
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Medical Device and Diagnostics Companies
  • Academic and Medical Research Institutions
  • Government and Nonprofit Research Organizations
  • Other Clinical Research Organizations
Companies covered
  • Cytel
  • TriNetX
  • Saama
  • Simulations Plus
  • Statsols
  • ConcertAI
  • Phesi
  • Faro Health
  • QuantHealth
  • Unlearn
  • MMS
  • Berry Consultants
  • ZS
  • Clinion
  • Nurocor
  • Lindus Health
  • TrialKey
  • Protocol Builder
  • Medidata
  • IQVIA
  • Certara

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI Clinical Trial Design Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 End-to-End Trial Design Platforms
  5. 1.2.3 Protocol Authoring and Optimization Software
  6. 1.2.4 Trial Simulation and Outcome Prediction Software
  7. 1.2.5 Adaptive and Bayesian Design Software
  8. 1.2.6 Feasibility and Enrollment Design Software
  9. 1.2.7 Synthetic Control and Digital Twin Software
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global AI Clinical Trial Design Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Pharmaceutical and Biotechnology Companies
  13. 1.3.3 Contract Research Organizations
  14. 1.3.4 Medical Device and Diagnostics Companies
  15. 1.3.5 Academic and Medical Research Institutions
  16. 1.3.6 Government and Nonprofit Research Organizations
  17. 1.3.7 Other Clinical Research Organizations
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global AI Clinical Trial Design Software Growth Trends by Region
  20. 1.5.1 Global AI Clinical Trial Design Software Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 AI Clinical Trial Design Software Market Size by Region (2021-2026)
  22. 1.5.3 AI Clinical Trial Design Software Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global AI Clinical Trial Design Software Market Dynamics
  1. 2.1 AI Clinical Trial Design Software Industry Trends
  2. 2.2 AI Clinical Trial Design Software Industry Drivers
  3. 2.3 AI Clinical Trial Design Software Industry Opportunities and Challenges
  4. 2.4 AI Clinical Trial Design Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI Clinical Trial Design Software Revenue by Company (2021-2026)
  2. 3.2 Global AI Clinical Trial Design Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI Clinical Trial Design Software Key Company Head office and Area Served
  4. 3.4 Global AI Clinical Trial Design Software Company, Product Type & Application
  5. 3.5 Global AI Clinical Trial Design Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI Clinical Trial Design Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI Clinical Trial Design Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI Clinical Trial Design Software Tier 1, Tier 2, and Tier 3
4 AI Clinical Trial Design Software Market by Type
  1. 4.1 Global AI Clinical Trial Design Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI Clinical Trial Design Software Market Size by Type (2021-2032)
  3. 4.3 Global AI Clinical Trial Design Software Market Size Share by Type (2021-2032)
5 AI Clinical Trial Design Software Market by Application
  1. 5.1 Global AI Clinical Trial Design Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Clinical Trial Design Software Market Size by Application (2021-2032)
  3. 5.3 Global AI Clinical Trial Design Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Cytel
  2. 6.1.1 Cytel Company Information
  3. 6.1.2 Cytel Business Overview
  4. 6.1.3 Cytel AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Cytel AI Clinical Trial Design Software Product Portfolio
  6. 6.1.5 Cytel Recent Developments
  7. 6.2 TriNetX
  8. 6.2.1 TriNetX Company Information
  9. 6.2.2 TriNetX Business Overview
  10. 6.2.3 TriNetX AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 TriNetX AI Clinical Trial Design Software Product Portfolio
  12. 6.2.5 TriNetX Recent Developments
  13. 6.3 Saama
  14. 6.3.1 Saama Company Information
  15. 6.3.2 Saama Business Overview
  16. 6.3.3 Saama AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Saama AI Clinical Trial Design Software Product Portfolio
  18. 6.3.5 Saama Recent Developments
  19. 6.4 Simulations Plus
  20. 6.4.1 Simulations Plus Company Information
  21. 6.4.2 Simulations Plus Business Overview
  22. 6.4.3 Simulations Plus AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Simulations Plus AI Clinical Trial Design Software Product Portfolio
  24. 6.4.5 Simulations Plus Recent Developments
  25. 6.5 Statsols
  26. 6.5.1 Statsols Company Information
  27. 6.5.2 Statsols Business Overview
  28. 6.5.3 Statsols AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Statsols AI Clinical Trial Design Software Product Portfolio
  30. 6.5.5 Statsols Recent Developments
  31. 6.6 ConcertAI
  32. 6.6.1 ConcertAI Company Information
  33. 6.6.2 ConcertAI Business Overview
  34. 6.6.3 ConcertAI AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 ConcertAI AI Clinical Trial Design Software Product Portfolio
  36. 6.6.5 ConcertAI Recent Developments
  37. 6.7 Phesi
  38. 6.7.1 Phesi Company Information
  39. 6.7.2 Phesi Business Overview
  40. 6.7.3 Phesi AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Phesi AI Clinical Trial Design Software Product Portfolio
  42. 6.7.5 Phesi Recent Developments
  43. 6.8 Faro Health
  44. 6.8.1 Faro Health Company Information
  45. 6.8.2 Faro Health Business Overview
  46. 6.8.3 Faro Health AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Faro Health AI Clinical Trial Design Software Product Portfolio
  48. 6.8.5 Faro Health Recent Developments
  49. 6.9 QuantHealth
  50. 6.9.1 QuantHealth Company Information
  51. 6.9.2 QuantHealth Business Overview
  52. 6.9.3 QuantHealth AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 QuantHealth AI Clinical Trial Design Software Product Portfolio
  54. 6.9.5 QuantHealth Recent Developments
  55. 6.10 Unlearn
  56. 6.10.1 Unlearn Company Information
  57. 6.10.2 Unlearn Business Overview
  58. 6.10.3 Unlearn AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Unlearn AI Clinical Trial Design Software Product Portfolio
  60. 6.10.5 Unlearn Recent Developments
  61. 6.11 MMS
  62. 6.11.1 MMS Company Information
  63. 6.11.2 MMS Business Overview
  64. 6.11.3 MMS AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 MMS AI Clinical Trial Design Software Product Portfolio
  66. 6.11.5 MMS Recent Developments
  67. 6.12 Berry Consultants
  68. 6.12.1 Berry Consultants Company Information
  69. 6.12.2 Berry Consultants Business Overview
  70. 6.12.3 Berry Consultants AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Berry Consultants AI Clinical Trial Design Software Product Portfolio
  72. 6.12.5 Berry Consultants Recent Developments
  73. 6.13 ZS
  74. 6.13.1 ZS Company Information
  75. 6.13.2 ZS Business Overview
  76. 6.13.3 ZS AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 ZS AI Clinical Trial Design Software Product Portfolio
  78. 6.13.5 ZS Recent Developments
  79. 6.14 Clinion
  80. 6.14.1 Clinion Company Information
  81. 6.14.2 Clinion Business Overview
  82. 6.14.3 Clinion AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Clinion AI Clinical Trial Design Software Product Portfolio
  84. 6.14.5 Clinion Recent Developments
  85. 6.15 Nurocor
  86. 6.15.1 Nurocor Company Information
  87. 6.15.2 Nurocor Business Overview
  88. 6.15.3 Nurocor AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Nurocor AI Clinical Trial Design Software Product Portfolio
  90. 6.15.5 Nurocor Recent Developments
  91. 6.16 Lindus Health
  92. 6.16.1 Lindus Health Company Information
  93. 6.16.2 Lindus Health Business Overview
  94. 6.16.3 Lindus Health AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Lindus Health AI Clinical Trial Design Software Product Portfolio
  96. 6.16.5 Lindus Health Recent Developments
  97. 6.17 TrialKey
  98. 6.17.1 TrialKey Company Information
  99. 6.17.2 TrialKey Business Overview
  100. 6.17.3 TrialKey AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 TrialKey AI Clinical Trial Design Software Product Portfolio
  102. 6.17.5 TrialKey Recent Developments
  103. 6.18 Protocol Builder
  104. 6.18.1 Protocol Builder Company Information
  105. 6.18.2 Protocol Builder Business Overview
  106. 6.18.3 Protocol Builder AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Protocol Builder AI Clinical Trial Design Software Product Portfolio
  108. 6.18.5 Protocol Builder Recent Developments
  109. 6.19 Medidata
  110. 6.19.1 Medidata Company Information
  111. 6.19.2 Medidata Business Overview
  112. 6.19.3 Medidata AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Medidata AI Clinical Trial Design Software Product Portfolio
  114. 6.19.5 Medidata Recent Developments
  115. 6.20 IQVIA
  116. 6.20.1 IQVIA Company Information
  117. 6.20.2 IQVIA Business Overview
  118. 6.20.3 IQVIA AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 IQVIA AI Clinical Trial Design Software Product Portfolio
  120. 6.20.5 IQVIA Recent Developments
  121. 6.21 Certara
  122. 6.21.1 Certara Company Information
  123. 6.21.2 Certara Business Overview
  124. 6.21.3 Certara AI Clinical Trial Design Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Certara AI Clinical Trial Design Software Product Portfolio
  126. 6.21.5 Certara Recent Developments
7 North America
  1. 7.1 North America AI Clinical Trial Design Software Market Size (2021-2032)
  2. 7.2 North America AI Clinical Trial Design Software Market Size by Type
  3. 7.2.1 North America AI Clinical Trial Design Software Market Size by Type (2021-2026)
  4. 7.2.2 North America AI Clinical Trial Design Software Market Size by Type (2027-2032)
  5. 7.2.3 North America AI Clinical Trial Design Software Market Share by Type (2021-2032)
  6. 7.3 North America AI Clinical Trial Design Software Market Size by Application
  7. 7.3.1 North America AI Clinical Trial Design Software Market Size by Application (2021-2026)
  8. 7.3.2 North America AI Clinical Trial Design Software Market Size by Application (2027-2032)
  9. 7.3.3 North America AI Clinical Trial Design Software Market Share by Application (2021-2032)
  10. 7.4 North America AI Clinical Trial Design Software Market Size by Country
  11. 7.4.1 North America AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI Clinical Trial Design Software Market Size by Country (2021-2026)
  13. 7.4.3 North America AI Clinical Trial Design Software Market Size by Country (2027-2032)
  14. 7.4.4 North America AI Clinical Trial Design Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI Clinical Trial Design Software Market Size (2021-2032)
  2. 8.2 Europe AI Clinical Trial Design Software Market Size by Type
  3. 8.2.1 Europe AI Clinical Trial Design Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI Clinical Trial Design Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI Clinical Trial Design Software Market Share by Type (2021-2032)
  6. 8.3 Europe AI Clinical Trial Design Software Market Size by Application
  7. 8.3.1 Europe AI Clinical Trial Design Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI Clinical Trial Design Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI Clinical Trial Design Software Market Share by Application (2021-2032)
  10. 8.4 Europe AI Clinical Trial Design Software Market Size by Country
  11. 8.4.1 Europe AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI Clinical Trial Design Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI Clinical Trial Design Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI Clinical Trial Design Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI Clinical Trial Design Software Market Size (2021-2032)
  2. 9.2 China AI Clinical Trial Design Software Market Size by Type
  3. 9.2.1 China AI Clinical Trial Design Software Market Size by Type (2021-2026)
  4. 9.2.2 China AI Clinical Trial Design Software Market Size by Type (2027-2032)
  5. 9.2.3 China AI Clinical Trial Design Software Market Share by Type (2021-2032)
  6. 9.3 China AI Clinical Trial Design Software Market Size by Application
  7. 9.3.1 China AI Clinical Trial Design Software Market Size by Application (2021-2026)
  8. 9.3.2 China AI Clinical Trial Design Software Market Size by Application (2027-2032)
  9. 9.3.3 China AI Clinical Trial Design Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI Clinical Trial Design Software Market Size (2021-2032)
  2. 10.2 Asia AI Clinical Trial Design Software Market Size by Type
  3. 10.2.1 Asia AI Clinical Trial Design Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI Clinical Trial Design Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI Clinical Trial Design Software Market Share by Type (2021-2032)
  6. 10.3 Asia AI Clinical Trial Design Software Market Size by Application
  7. 10.3.1 Asia AI Clinical Trial Design Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI Clinical Trial Design Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI Clinical Trial Design Software Market Share by Application (2021-2032)
  10. 10.4 Asia AI Clinical Trial Design Software Market Size by Country
  11. 10.4.1 Asia AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI Clinical Trial Design Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI Clinical Trial Design Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI Clinical Trial Design Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI Clinical Trial Design Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI Clinical Trial Design Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI Clinical Trial Design Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI Clinical Trial Design Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst